trial · primary record
TriAdeno vaccine
Adenocarcinoma
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 52 |
| Primary completion | 2028-06-15 |
| Primary endpoint | To determine the effect of TriAdeno vaccine with N-803 on immune infiltration of the local tumor environment |
| Registry ID | NCT07574541 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:32:19.179Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07574541
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.